Larimar Therapeutics (LRMR) Cash from Investing Activities (2016 - 2020)
Historic Cash from Investing Activities for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to -$23.5 million.
- Larimar Therapeutics' Cash from Investing Activities fell 4699000.0% to -$23.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $17.1 million, marking a year-over-year increase of 2069036.14%. This contributed to the annual value of -$85.4 million for FY2024, which is 35601.0% down from last year.
- According to the latest figures from Q4 2020, Larimar Therapeutics' Cash from Investing Activities is -$23.5 million, which was down 4699000.0% from -$8000.0 recorded in Q3 2020.
- Over the past 5 years, Larimar Therapeutics' Cash from Investing Activities peaked at $41.4 million during Q2 2020, and registered a low of -$47.4 million during Q3 2018.
- In the last 5 years, Larimar Therapeutics' Cash from Investing Activities had a median value of $8.3 million in 2018 and averaged $5.1 million.
- Examining YoY changes over the last 5 years, Larimar Therapeutics' Cash from Investing Activities showed a top increase of 503107.14% in 2020 and a maximum decrease of 4699000.0% in 2020.
- Quarter analysis of 5 years shows Larimar Therapeutics' Cash from Investing Activities stood at $16.9 million in 2016, then fell by 24.97% to $12.7 million in 2017, then rose by 12.43% to $14.3 million in 2018, then crashed by 100.35% to -$50000.0 in 2019, then tumbled by 46990.0% to -$23.5 million in 2020.
- Its last three reported values are -$23.5 million in Q4 2020, -$8000.0 for Q3 2020, and $41.4 million during Q2 2020.